Monsanto Company (NYSE:MON)‘s stock had its “equal weight” rating reiterated by Barclays PLC in a research note issued to investors on Thursday. They presently have a $124.00 price target on the basic materials company’s stock, up from their previous price target of $120.00. Barclays PLC’s target price would indicate a potential upside of 3.57% from the stock’s previous close.

MON has been the subject of a number of other reports. Zacks Investment Research downgraded Monsanto from a “buy” rating to a “hold” rating in a report on Tuesday, September 5th. BMO Capital Markets restated a “buy” rating and issued a $128.00 target price on shares of Monsanto in a research note on Friday, September 1st. BidaskClub upgraded Monsanto from a “sell” rating to a “hold” rating in a research note on Saturday, August 19th. Royal Bank Of Canada restated a “sector perform” rating and issued a $128.00 target price (up from $120.00) on shares of Monsanto in a research note on Thursday, June 29th. Finally, Vetr upgraded Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price for the company in a research note on Wednesday, July 12th. Ten investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $125.45.

Monsanto (NYSE:MON) opened at 119.73 on Thursday. Monsanto has a 1-year low of $97.35 and a 1-year high of $120.50. The firm has a 50-day moving average price of $118.25 and a 200-day moving average price of $117.04. The firm has a market capitalization of $52.62 billion, a PE ratio of 23.53 and a beta of 1.07. Monsanto also was the recipient of unusually large options trading on Wednesday. Stock investors acquired 63,484 put options on the company. This represents an increase of 1,793% compared to the typical volume of 3,354 put options.

Monsanto (NYSE:MON) last issued its quarterly earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.41) by $0.61. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The firm had revenue of $2.69 billion during the quarter, compared to the consensus estimate of $2.51 billion. During the same period last year, the business posted $0.07 EPS. The business’s revenue was up 4.8% compared to the same quarter last year. Equities analysts expect that Monsanto will post $5.65 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Barclays PLC Reiterates Equal Weight Rating for Monsanto Company (MON)” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://www.thecerbatgem.com/2017/10/07/barclays-plc-reiterates-equal-weight-rating-for-monsanto-company-mon.html.

In other Monsanto news, COO Brett D. Begemann sold 22,640 shares of Monsanto stock in a transaction dated Monday, September 25th. The stock was sold at an average price of $120.03, for a total transaction of $2,717,479.20. Following the completion of the transaction, the chief operating officer now owns 85,439 shares in the company, valued at approximately $10,255,243.17. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Duraiswami Narain sold 2,860 shares of Monsanto stock in a transaction dated Monday, September 25th. The shares were sold at an average price of $120.00, for a total value of $343,200.00. The disclosure for this sale can be found here. Insiders have sold a total of 77,910 shares of company stock valued at $9,242,439 in the last quarter. Company insiders own 0.79% of the company’s stock.

A number of hedge funds have recently added to or reduced their stakes in the business. Yorkville Capital Management LLC boosted its stake in Monsanto by 2.7% during the 2nd quarter. Yorkville Capital Management LLC now owns 18,800 shares of the basic materials company’s stock valued at $2,225,000 after purchasing an additional 500 shares during the last quarter. Paulson & CO. Inc. boosted its stake in Monsanto by 348.5% during the 2nd quarter. Paulson & CO. Inc. now owns 159,200 shares of the basic materials company’s stock valued at $18,843,000 after purchasing an additional 123,700 shares during the last quarter. Intl Fcstone Inc. acquired a new position in Monsanto during the 2nd quarter valued at about $794,000. Paradigm Financial Advisors LLC boosted its stake in Monsanto by 44.7% during the 2nd quarter. Paradigm Financial Advisors LLC now owns 17,316 shares of the basic materials company’s stock valued at $2,050,000 after purchasing an additional 5,351 shares during the last quarter. Finally, Ashburton Jersey Ltd boosted its stake in Monsanto by 20.4% during the 2nd quarter. Ashburton Jersey Ltd now owns 21,642 shares of the basic materials company’s stock valued at $2,562,000 after purchasing an additional 3,660 shares during the last quarter. Institutional investors and hedge funds own 74.81% of the company’s stock.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Analyst Recommendations for Monsanto (NYSE:MON)

Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.